etoposide has been researched along with Carcinoma 256, Walker in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalla Costa, T; Magni, P; Pigatto, MC; Tosca, EM | 1 |
| Alberto Paciucci, P; Chinol, M; Gennuso, R; Goldsmith, SJ; Holland, JF; Nieves, J; Spigelman, MK; Vallabhajosula, S; Zappulla, RA | 1 |
| Egle, A; Grunicke, H; Hofmann, J; Ueberall, F | 1 |
3 other study(ies) available for etoposide and Carcinoma 256, Walker
| Article | Year |
|---|---|
A Population Dynamic Energy Budget-Based Tumor Growth Inhibition Model for Etoposide Effects on Wistar Rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cachexia; Carcinoma 256, Walker; Cell Line, Tumor; Cell Survival; Etoposide; Humans; Male; Models, Biological; Random Allocation; Rats; Rats, Wistar; Xenograft Model Antitumor Assays | 2019 |
Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Carcinoma 256, Walker; Etoposide; Female; Indium Radioisotopes; Liposomes; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley | 1993 |
B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance.
Topics: Actins; Animals; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma 256, Walker; Cell Division; Cell Line; Dihydropyridines; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; HeLa Cells; Humans; KB Cells; Mammary Neoplasms, Experimental; Molecular Structure; Rats | 1991 |